mirtazapine has been researched along with Ecchymosis in 1 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
Ecchymosis: Extravasation of blood into the skin, resulting in a nonelevated, rounded or irregular, blue or purplish patch, larger than a petechia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Demet, MM | 1 |
| Mizrak, S | 1 |
| Esen-Danaci, A | 1 |
1 other study available for mirtazapine and Ecchymosis
| Article | Year |
|---|---|
Mirtazapine-induced arthralgia and coagulopathy: a case report.
Topics: Ankle Joint; Antidepressive Agents, Tricyclic; Arthralgia; Ecchymosis; Female; Humans; Knee Joint; M | 2005 |